Angiodynamics, Inc. · NASDAQ:ANGO
Armistice Capital, LLC reported a 5.16% stake in Angiodynamics, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed May 15, 2025
Armistice Capital, LLC reported a 5.16% stake in Angiodynamics, Inc., 2,094,000 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G).
- Stake
- 5.16%
- Shares
- 2,094,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 5.16% | 2,094,000 |
| Steven Boyd | 5.16% | 2,094,000 |
Source
Related
- Angiodynamics, Inc.
- Armistice Capital, LLC
- Angiodynamics, Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · Feb 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2025
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2025
- Form 4 · Nighan Warren JR · Jul 31, 2026
- Form 4 · Piccinini Laura · Jul 24, 2026
- Form 4 · Nighan Warren JR · Jul 24, 2026
- Form 4 · Trowbridge Stephen A · Jul 24, 2026
- Form 4 · Clemmer James C · Jul 24, 2026